Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H28N2O5 |
| Molecular Weight | 376.4467 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
InChI
InChIKey=GBXSMTUPTTWBMN-UAGQMJEPSA-N
InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16+,17-/m0/s1
(2S)-1-((2S)-2-(((1R)-1-(Ethoxycarbonyl)-3-Phenylpropyl)Amino)Propanoyl)Pyrrolidine-2-Carboxylic Acid is an epimer and synthetic impurity of Enalpril which is an angiotensin-converting-enzyme (ACE) inhibitor used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5362032
Created by
admin on Sat Dec 16 05:44:29 GMT 2023 , Edited by admin on Sat Dec 16 05:44:29 GMT 2023
|
PRIMARY | |||
|
DTXSID601181936
Created by
admin on Sat Dec 16 05:44:29 GMT 2023 , Edited by admin on Sat Dec 16 05:44:29 GMT 2023
|
PRIMARY | |||
|
76420-74-1
Created by
admin on Sat Dec 16 05:44:29 GMT 2023 , Edited by admin on Sat Dec 16 05:44:29 GMT 2023
|
PRIMARY | |||
|
S7IJ7OBG9V
Created by
admin on Sat Dec 16 05:44:29 GMT 2023 , Edited by admin on Sat Dec 16 05:44:29 GMT 2023
|
PRIMARY |
